A new cancer drug under development could begin phase 1 testing in humans next year after it obtained good results in treating eight types of cancers in animal tests, the National Health Research Institutes (NHRI) announced yesterday.
Hsieh Hsing-pang (謝興邦), a researcher at the NHRI’s Institute of Biotechnology and Pharmaceutical Research (IBPR), said at a media briefing that 40 late-stage cancer patients who have not been helped by any available treatment, but are still in decent physical condition, are to be recruited for phase 1 clinical trials next year.
The new drug, known as DBPR144, is a small molecule known as a multi-target kinase inhibitor, Hsieh said.
Photo: CNA
A kinase is an enzyme that controls important cell functions, and it can be active in the growth of some types of cancer cells.
The eight types of cancers against which it showed success through in vivo studies in animals were pancreatic, oral, gastric, liver, bladder, prostate and colorectal cancer, as well as acute myeloid leukemia, Hsieh said.
“Because it is particularly effective in gastroenterology-related cancers, we are likely to first target patients with pancreatic, liver, bladder and gastric cancer in the initial clinical trial,” he said.
Multi-target drugs, which take aim at several targets rather than more common medications that only target a single biological substance, more effectively inhibit cancer cell proliferation and overcome drug resistance, he said.
During the phase 1 trial, the volunteers are to be given DBPR114 once a week to determine safe dosages of the drug, Hsieh said.
Chen Chiu-heng (陳丘泓), general manager of Launxp Biomedical Co, which will be responsible for manufacturing the drug, said cancer patients from Taiwan and Australia are to be recruited to take part in the initial trial, which is expected to take two years.
Phase 2 and phase 3 trials, which should each take two to three years, will focus on cancers that responded promisingly to the drug in phase 1.
At least six years will be needed to complete human trials, Chen said.
“This novel, multi-targeted agent is our new hope for treating cancer patients,” IBPR Director Chang Jang-yang (張俊彥) said.
Cancer has been the top cause of death in Taiwan for 41 years, he said, and the five-year survival rates among patients with major types of cancer remained low, especially the 5 percent rate for people with pancreatic cancer.
China has reserved offshore airspace in the Yellow Sea and East China Sea from March 27 to May 6, issuing alerts usually used to warn of military exercises, although no such exercises have been announced, the Wall Street Journal (WSJ) reported yesterday. Reserving such a large area for 40 days without explanation is an “unusual step,” as military exercises normally only last a few days, the paper said. These alerts, known as Notice to Air Missions (Notams), “are intended to inform pilots and aviation authorities of temporary airspace hazards or restrictions,” the article said. The airspace reserved in the alert is
NAMING SPAT: The foreign ministry called on Denmark to propose an acceptable solution to the erroneous nationality used for Taiwanese on residence permits Taiwan has revoked some privileges for Danish diplomatic staff over a Danish permit that lists “Taiwan” as “China,” Eric Huang (黃鈞耀), head of the Ministry of Foreign Affairs’ Department of European Affairs, told a news conference in Taipei yesterday. Reporters asked Huang whether the Danish government had responded to the ministry’s request that it correct the nationality on Danish residence permits of Taiwanese, which has been listed as “China” since 2024. Taiwan’s representative office in Denmark continues to communicate with the Danish government, and the ministry has revoked some privileges previously granted to Danish representatives in Taiwan and would continue to review
More than 6,000 Taiwanese students have participated in exchange programs in China over the past two years, despite the Mainland Affairs Council’s (MAC) “orange light” travel advisory, government records showed. The MAC’s publicly available registry showed that Taiwanese college and university students who went on exchange programs across the Strait numbered 3,592 and 2,966 people respectively. The National Immigration Agency data revealed that 2,296 and 2,551 Chinese students visited Taiwan for study in the same two years. A review of the Web sites of publicly-run universities and colleges showed that Taiwanese higher education institutions continued to recruit students for Chinese educational programs without
The first bluefin tuna of the season, brought to shore in Pingtung County and weighing 190kg, was yesterday auctioned for NT$10,600 (US$333.5) per kilogram, setting a record high for the local market. The auction was held at the fish market in Donggang Fishing Harbor, where the Siaoliouciou Island-registered fishing vessel Fu Yu Ching No. 2 delivered the “Pingtung First Tuna” it had caught for bidding. Bidding was intense, and the tuna was ultimately jointly purchased by a local restaurant and a local company for NT$10,600 per kilogram — NT$300 ,more than last year — for a total of NT$2.014 million. The 67-year-old skipper
RSS